We used this method to calculate ESTIMATE scores for glioma patients, and the results showed that SLC11A1 was highly positively associated with stromal scores, immune scores and ESTIMATE scores but significantly negatively associated with glioma tumor purity (Supplementary Figure 5A). Here, SLC11A1 is linked to central nervous system cancer.